Resultados de la búsqueda 281-290 of 16569 for immunothérapie
Rochester, Minn. The purpose of this study is to follow Mayo Clinic patients with severe brachial plexus injuries who underwent upper limb amputation. Pre- ...
All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...
The overall goals of this study are to evaluate similarities and differences of the known genetic and non-genetic epidemiological factors associated with ...
Los tratamientos para la leucemia linfocítica crónica pueden incluir una estrategia de espera vigilante, terapia dirigida, quimioterapia, inmunoterapia y ...
Monoclonal antibodies, such as cetuximab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find tumor ...
Infórmate más sobre los síntomas, los factores de riesgo y el tratamiento de este cáncer del sistema linfático que provoca la inflamación de los ganglios ...
The percentage of subjects who can enroll on an A2 CAR T-cell therapy study within approximately 6 months of documentation of HLA-A LOH status. The percentage ...
The purpose of this study is to evaluate the feasibility of molecular characterization based on tumor mutational burden (TMB) for participant stratification ...
The purpose of this study is to test a new technology called Next Generation Sequencing (NGS) that may help identify this risk associated with precursor ...
The purpose of this study is to compare the effects, good and/or bad of two treatment methods on subjects and their cancer. Proton beam radiation therapy is one ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?